The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 29,639 2,359,767 SH   SOLE   2,359,767 0 0
Aldeyra Therapeutics Inc COM 01438T106 6,317 484,096 SH   SOLE   484,096 0 0
Anavex Life Sciences Corp COM NEW 032797300 1,868 724,205 SH   SOLE   724,205 0 0
Biohaven Pharmactl Hldg Co L COM G11196105 27,916 749,815 SH   SOLE   749,815 0 0
Catasys Inc COM 149049504 102 9,081 SH   SOLE   9,081 0 0
Chromadex Corp COM NEW 171077407 192 47,866 SH   SOLE   47,866 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 30,471 4,062,791 SH   SOLE   4,062,791 0 0
Eiger Biopharmaceuticals Inc COM 28249U105 910 75,238 SH   SOLE   75,238 0 0
Electrocore Inc COM 28531P103 5,667 396,825 SH   SOLE   396,825 0 0
Entera Bio Ltd SHS M40527109 2,406 475,540 SH   SOLE   475,540 0 0
Evoke Pharma Inc COM 30049G104 825 275,000 SH   SOLE   275,000 0 0
Galmed Pharmaceuticals Ltd SHS M47238106 2,881 210,000 SH   SOLE   210,000 0 0
Krystal Biotech Inc COM 501147102 5,103 300,000 SH   SOLE   300,000 0 0
Lipocine Inc New COM 53630X104 69 50,000 SH   SOLE   50,000 0 0
Soligenix Inc. COM 834223307 1,525 837,800 SH   SOLE   837,800 0 0
Vascular Biogenics LTD COM M96883109 1,489 896,771 SH   SOLE   896,771 0 0
Volition RX LTD COM 928661107 916 321,413 SH   SOLE   321,413 0 0